182 related articles for article (PubMed ID: 23228357)
1. Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007-2009.
Gessner BD; Sanou O; Drabo A; Tamekloe TA; Yaro S; Tall H; Moïsi JC; Mueller JE; Njanpop-LaFourcade BM
Vaccine; 2012 Dec; 30 Suppl 6():G41-5. PubMed ID: 23228357
[TBL] [Abstract][Full Text] [Related]
2. Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo.
Traore Y; Tameklo TA; Njanpop-Lafourcade BM; Lourd M; Yaro S; Niamba D; Drabo A; Mueller JE; Koeck JL; Gessner BD
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S181-9. PubMed ID: 19191614
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso.
Yaro S; Lourd M; Traoré Y; Njanpop-Lafourcade BM; Sawadogo A; Sangare L; Hien A; Ouedraogo MS; Sanou O; Parent du Châtelet I; Koeck JL; Gessner BD
Clin Infect Dis; 2006 Sep; 43(6):693-700. PubMed ID: 16912941
[TBL] [Abstract][Full Text] [Related]
4. Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.
Kambiré D; Soeters HM; Ouédraogo-Traoré R; Medah I; Sangare L; Yaméogo I; Sawadogo G; Ouédraogo AS; Hema-Ouangraoua S; McGee L; Srinivasan V; Aké F; Congo-Ouédraogo M; Sanou S; Ba AK; Novak RT; Van Beneden C;
PLoS One; 2016; 11(11):e0166384. PubMed ID: 27832151
[TBL] [Abstract][Full Text] [Related]
5. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
6. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, Burkina Faso, 2016-2017.
Soeters HM; Kambiré D; Sawadogo G; Ouédraogo-Traoré R; Bicaba B; Medah I; Sangaré L; Ouédraogo AS; Ouangraoua S; Yaméogo I; Congo-Ouédraogo M; Ky Ba A; Aké F; Srinivasan V; Novak RT; McGee L; Whitney CG; Van Beneden C
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S253-S262. PubMed ID: 31671444
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of pneumococci causing meningitis in Spain and prevalence among such isolates of serotypes contained in the 7-valent pneumococcal conjugate vaccine.
Fenoll A; Giménez MJ; Vicioso MD; Granizo JJ; Robledo O; Aguilar L
J Antimicrob Chemother; 2009 Dec; 64(6):1338-40. PubMed ID: 19828490
[No Abstract] [Full Text] [Related]
8. Streptococcus pneumoniae invasive infections in Burkina Faso, 2007 to 2011.
Chaïbou Y; Sanou I; Congo-Ouedraogo M; Kienou MC; Ouattara K; Somlaré H; Traoré AS; Sangaré L
Med Mal Infect; 2014 Mar; 44(3):117-22. PubMed ID: 24612507
[TBL] [Abstract][Full Text] [Related]
9. Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children.
Azzari C; Moriondo M; Cortimiglia M; Valleriani C; Canessa C; Indolfi G; Ricci S; Nieddu F; de Martino M; Resti M;
Vaccine; 2012 Mar; 30(16):2701-5. PubMed ID: 22178097
[TBL] [Abstract][Full Text] [Related]
10. Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine.
Bozio CH; Abdul-Karim A; Abenyeri J; Abubakari B; Ofosu W; Zoya J; Ouattara M; Srinivasan V; Vuong JT; Opare D; Asiedu-Bekoe F; Lessa FC
PLoS One; 2018; 13(9):e0203205. PubMed ID: 30192772
[TBL] [Abstract][Full Text] [Related]
11. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
Motlova J; Benes C; Kriz P
Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
[TBL] [Abstract][Full Text] [Related]
12. Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014-2015.
Kambiré D; Soeters HM; Ouédraogo-Traoré R; Medah I; Sangaré L; Yaméogo I; Sawadogo G; Ouédraogo AS; Ouangraoua S; McGee L; Srinivasan V; Aké F; Congo-Ouédraogo M; Ky Ba A; Whitney CG; Novak RT; Van Beneden C;
J Infect; 2018 Mar; 76(3):270-279. PubMed ID: 29253559
[TBL] [Abstract][Full Text] [Related]
13. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.
Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP;
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for Streptococcus pneumoniae meningitis in children aged <5 years: implications for immunization in Uganda.
Kisakye A; Makumbi I; Nansera D; Lewis R; Braka F; Wobudeya E; Chaplain D; Nalumansi E; Mbabazi W; Gessner BD
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S153-61. PubMed ID: 19191611
[TBL] [Abstract][Full Text] [Related]
15. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.
von Kries R; Siedler A; Schmitt HJ; Reinert RR
Clin Infect Dis; 2000 Aug; 31(2):482-7. PubMed ID: 10987709
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
Shibl AM; Memish ZA; Al-Kattan KM
Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
[TBL] [Abstract][Full Text] [Related]
17. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany.
Imöhl M; Möller J; Reinert RR; Perniciaro S; van der Linden M; Aktas O
BMC Infect Dis; 2015 Feb; 15():61. PubMed ID: 25885764
[TBL] [Abstract][Full Text] [Related]
18. Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis.
Brandileone MC; de Andrade AL; Di Fabio JL; Guerra ML; Austrian R
J Infect Dis; 2003 Apr; 187(8):1206-12. PubMed ID: 12695999
[TBL] [Abstract][Full Text] [Related]
19. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
Muñoz-Almagro C; Ciruela P; Esteva C; Marco F; Navarro M; Bartolome R; Sauca G; Gallés C; Morta M; Ballester F; Raga X; Selva L;
J Infect; 2011 Aug; 63(2):151-62. PubMed ID: 21679725
[TBL] [Abstract][Full Text] [Related]
20. Rebound in the incidence of pneumococcal meningitis in northern France: effect of serotype replacement.
Alexandre C; Dubos F; Courouble C; Pruvost I; Varon E; ; Martinot A
Acta Paediatr; 2010 Nov; 99(11):1686-90. PubMed ID: 20626365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
